Lactate dehydrogenase levels predict coronavirus disease 2019 (COVID-19) severity and mortality: A pooled analysis
- PMID: 32738466
- PMCID: PMC7251362
- DOI: 10.1016/j.ajem.2020.05.073
Lactate dehydrogenase levels predict coronavirus disease 2019 (COVID-19) severity and mortality: A pooled analysis
Abstract
Coronavirus disease 2019 (COVID-19) infection has now reached a pandemic state, affecting more than a million patients worldwide. Predictors of disease outcomes in these patients need to be urgently assessed to decrease morbidity and societal burden. Lactate dehydrogenase (LDH) has been associated with worse outcomes in patients with viral infections. In this pooled analysis of 9 published studies (n = 1532 COVID-19 patients), we evaluated the association between elevated LDH levels measured at earliest time point in hospitalization and disease outcomes in patients with COVID-19. Elevated LDH levels were associated with a ~6-fold increase in odds of developing severe disease and a ~16-fold increase in odds of mortality in patients with COVID-19. Larger studies are needed to confirm these findings.
Keywords: COVID-19; Coronavirus; Lactate dehydrogenase.
Copyright © 2020 Elsevier Inc. All rights reserved.
Conflict of interest statement
Disclosure None.
Figures
Comment in
-
Linking lactate dehydrogenase to the severity of COVID-19 cannot ignore the employed methodology.Am J Emerg Med. 2021 Jul;45:652-653. doi: 10.1016/j.ajem.2020.10.077. Epub 2020 Nov 2. Am J Emerg Med. 2021. PMID: 33168383 Free PMC article. No abstract available.
-
Lactate dehydrogenase level as a COVID-19 severity marker.Am J Emerg Med. 2021 Jul;45:638-639. doi: 10.1016/j.ajem.2020.11.025. Epub 2020 Nov 15. Am J Emerg Med. 2021. PMID: 33246860 Free PMC article. No abstract available.
Similar articles
-
Laboratory findings of COVID-19: a systematic review and meta-analysis.Scand J Clin Lab Invest. 2020 Oct;80(6):441-447. doi: 10.1080/00365513.2020.1768587. Epub 2020 May 23. Scand J Clin Lab Invest. 2020. PMID: 32449374 Free PMC article.
-
Lactate dehydrogenase and susceptibility to deterioration of mild COVID-19 patients: a multicenter nested case-control study.BMC Med. 2020 Jun 3;18(1):168. doi: 10.1186/s12916-020-01633-7. BMC Med. 2020. PMID: 32493370 Free PMC article.
-
Lactate dehydrogenase and C-reactive protein as predictors of respiratory failure in CoVID-19 patients.Clin Chim Acta. 2020 Oct;509:135-138. doi: 10.1016/j.cca.2020.06.012. Epub 2020 Jun 9. Clin Chim Acta. 2020. PMID: 32531257 Free PMC article.
-
Laboratory abnormalities in children with mild and severe coronavirus disease 2019 (COVID-19): A pooled analysis and review.Clin Biochem. 2020 Jul;81:1-8. doi: 10.1016/j.clinbiochem.2020.05.012. Epub 2020 May 27. Clin Biochem. 2020. PMID: 32473151 Free PMC article. Review.
-
A meta-analysis of the impact of COVID-19 on liver dysfunction.Eur J Med Res. 2020 Nov 4;25(1):54. doi: 10.1186/s40001-020-00454-x. Eur J Med Res. 2020. PMID: 33148326 Free PMC article. Review.
Cited by
-
Point-of-care lung ultrasound predicts hyperferritinemia and hospitalization, but not elevated troponin in SARS-CoV-2 viral pneumonitis in children.Sci Rep. 2024 Mar 11;14(1):5899. doi: 10.1038/s41598-024-55590-9. Sci Rep. 2024. PMID: 38467670
-
Novel COVID-19 biomarkers identified through multi-omics data analysis: N-acetyl-4-O-acetylneuraminic acid, N-acetyl-L-alanine, N-acetyltriptophan, palmitoylcarnitine, and glycerol 1-myristate.Intern Emerg Med. 2024 Feb 28. doi: 10.1007/s11739-024-03547-1. Online ahead of print. Intern Emerg Med. 2024. PMID: 38416303
-
Role of biomarkers in prognostication of moderate and severe COVID-19 cases.J Family Med Prim Care. 2023 Dec;12(12):3186-3193. doi: 10.4103/jfmpc.jfmpc_423_23. Epub 2023 Dec 21. J Family Med Prim Care. 2023. PMID: 38361890 Free PMC article.
-
Comparison of influenza- and COVID-19-associated pulmonary aspergillosis in China.Eur J Clin Microbiol Infect Dis. 2024 Feb 7. doi: 10.1007/s10096-024-04772-4. Online ahead of print. Eur J Clin Microbiol Infect Dis. 2024. PMID: 38326545
-
Severe pediatric COVID-19: a review from the clinical and immunopathophysiological perspectives.World J Pediatr. 2024 Feb 6. doi: 10.1007/s12519-023-00790-y. Online ahead of print. World J Pediatr. 2024. PMID: 38321331 Review.
References
-
- World Health Organization Coronavirus disease 2019 (COVID-19) pandemic. 2020. https://www.who.int/emergencies/diseases/novel-coronavirus-2019
-
- Henry B, De Olivera MHS, S. B, M. P, G. L Hematologic, biochemical and immune marker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID 19): a meta-analysis. Clin Chem Lab Med. 2020. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
